Patterson-UTI
PTEN
285 hedge funds and large institutions have $2.47B invested in Patterson-UTI in 2022 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 93 increasing their positions, 96 reducing their positions, and 36 closing their positions.
53% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 36
6% more funds holding
Funds holding: 268 → 285 (+17)
3% less repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 96
1.64% less ownership
Funds ownership: 98.95% → 97.31% (-1.6%)
27% less capital invested
Capital invested by funds: $3.37B → $2.47B (-$906M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
90% less call options, than puts
Call options by funds: $3.85M | Put options by funds: $37M
Top Buyers
| 1 |
ACM
Anomaly Capital Management
New York
|
+$26.8M |
| 2 |
Millennium Management
New York
|
+$24M |
| 3 |
BlackRock
New York
|
+$20.3M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$18.6M |
| 5 |
CM
Castleark Management
Chicago,
Illinois
|
+$12.8M |
Top Sellers
| 1 |
SIG
Senator Investment Group
New York
|
-$36.2M |
| 2 |
VanEck Associates
New York
|
-$31.1M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$25.9M |
| 4 |
Holocene Advisors
New York
|
-$22.2M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$18.6M |
PTEN Hedge Fund Activity: Q3 2022 in Review
285 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Patterson-UTI (PTEN) for Q3 2022, worth a combined $2.47B — down 27% from $3.37B a quarter earlier.
Buyers outnumbered sellers: 55 funds opened new PTEN positions and 36 closed out — a net gain of 19 holders — while 93 added to existing stakes and 96 trimmed.
The largest buyer was Anomaly Capital Management, adding an estimated $26.8M. The largest seller was Senator Investment Group, exiting entirely with an estimated $36.2M sold.
- 285 institutional investors held Patterson-UTI (PTEN) as of Q3 2022, up from 268 in Q2 2022.
- Funds reported $2.47B of Patterson-UTI stock for Q3 2022, down 27% quarter-over-quarter.
- 55 funds opened new Patterson-UTI positions in Q3 2022 and 36 closed out, a net change of +19 holders.
- The largest Patterson-UTI buyer in Q3 2022 was Anomaly Capital Management, an estimated $26.8M added.
- The largest Patterson-UTI seller in Q3 2022 was Senator Investment Group, an estimated $36.2M sold.
Based on aggregated 13F filings for Q3 2022.